{"id":"https://openalex.org/W2739935697","doi":"https://doi.org/10.7224/1537-2073.2017-031","title":"Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis","display_name":"Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis","publication_year":2017,"publication_date":"2017-08-02","ids":{"openalex":"https://openalex.org/W2739935697","doi":"https://doi.org/10.7224/1537-2073.2017-031","mag":"2739935697","pmid":"https://pubmed.ncbi.nlm.nih.gov/30568562","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6295882"},"language":"en","primary_location":{"id":"doi:10.7224/1537-2073.2017-031","doi":"https://doi.org/10.7224/1537-2073.2017-031","is_oa":true,"landing_page_url":"https://doi.org/10.7224/1537-2073.2017-031","pdf_url":"https://meridian.allenpress.com/ijmsc/article-pdf/20/6/251/2093139/1537-2073_2017-031.pdf","source":{"id":"https://openalex.org/S2764607673","display_name":"International Journal of MS Care","issn_l":"1537-2073","issn":["1537-2073"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of MS Care","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://meridian.allenpress.com/ijmsc/article-pdf/20/6/251/2093139/1537-2073_2017-031.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034596227","display_name":"Andrew Thach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew V. Thach","raw_affiliation_strings":["From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071664431","display_name":"Carolyn M. Brown","orcid":"https://orcid.org/0000-0002-6976-7686","observed_orcids":["https://orcid.org/0000-0002-6976-7686"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]},{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carolyn M. Brown","raw_affiliation_strings":["College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","Novartis Pharmaceuticals Corp , East Hanover , NJ , USA","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corp , East Hanover , NJ , USA","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111424050","display_name":"Vivian Herrera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivian Herrera","raw_affiliation_strings":["employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","institution_ids":[]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050998332","display_name":"Rahul Sasan\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul Sasane","raw_affiliation_strings":["employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","institution_ids":[]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049953443","display_name":"Jamie C. Barner","orcid":"https://orcid.org/0000-0002-6078-8093","observed_orcids":["https://orcid.org/0000-0002-6078-8093"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie C. Barner","raw_affiliation_strings":["From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053028913","display_name":"Kentya C. Ford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kentya C. Ford","raw_affiliation_strings":["From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy , Austin , TX , USA ( AVT [now","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061941277","display_name":"Kenneth A. Lawson","orcid":"https://orcid.org/0000-0001-8520-8422","observed_orcids":["https://orcid.org/0000-0001-8520-8422"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth A. Lawson","raw_affiliation_strings":["employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","From The University of Texas at Austin College of Pharmacy, Austin, TX, USA ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"employed by Amgen Inc] , CMB , JCB, KCF, KAL) ; and","institution_ids":[]},{"raw_affiliation_string":"AVT [now employed by Amgen Inc], CMB, JCB, KCF, KAL); and Novartis Pharmaceuticals Corp, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin, 1 University Station A1930, Austin, TX 78712-0127;","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"From The University of Texas at Austin College of Pharmacy, Austin, TX, USA (","institution_ids":["https://openalex.org/I86519309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5071664431"],"corresponding_institution_ids":["https://openalex.org/I4210117619","https://openalex.org/I86519309"],"apc_list":null,"apc_paid":null,"fwci":2.2741,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.87458346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"20","issue":"6","first_page":"251","last_page":"259"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.10119999945163727,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9020000100135803},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.9750000238418579},{"id":"https://openalex.org/keywords/medication-beliefs","display_name":"medication beliefs","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-experience","display_name":"treatment experience","score":0.5109999775886536},{"id":"https://openalex.org/keywords/predictors-of-non-adherence","display_name":"predictors of non-adherence","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9515231251716614},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.6351068615913391},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.580035924911499},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.5465183258056641},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5315836071968079},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5108885169029236},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.4664292633533478},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.4650062024593353},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4193725287914276},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39630112051963806},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.36085522174835205},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1487124264240265},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1432284116744995}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.7224/1537-2073.2017-031","doi":"https://doi.org/10.7224/1537-2073.2017-031","is_oa":true,"landing_page_url":"https://doi.org/10.7224/1537-2073.2017-031","pdf_url":"https://meridian.allenpress.com/ijmsc/article-pdf/20/6/251/2093139/1537-2073_2017-031.pdf","source":{"id":"https://openalex.org/S2764607673","display_name":"International Journal of MS Care","issn_l":"1537-2073","issn":["1537-2073"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of MS Care","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5269261","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6295882","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6295882","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6295882","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J MS Care","raw_type":"Text"},{"id":"pmid:30568562","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30568562","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of MS care","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7224/1537-2073.2017-031","doi":"https://doi.org/10.7224/1537-2073.2017-031","is_oa":true,"landing_page_url":"https://doi.org/10.7224/1537-2073.2017-031","pdf_url":"https://meridian.allenpress.com/ijmsc/article-pdf/20/6/251/2093139/1537-2073_2017-031.pdf","source":{"id":"https://openalex.org/S2764607673","display_name":"International Journal of MS Care","issn_l":"1537-2073","issn":["1537-2073"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of MS Care","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2739935697.pdf","grobid_xml":"https://content.openalex.org/works/W2739935697.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1581887055","https://openalex.org/W1845225129","https://openalex.org/W1963494741","https://openalex.org/W1963760538","https://openalex.org/W1963767460","https://openalex.org/W1971061593","https://openalex.org/W1979211737","https://openalex.org/W1982508920","https://openalex.org/W1982625813","https://openalex.org/W1984705645","https://openalex.org/W1986021048","https://openalex.org/W1989806530","https://openalex.org/W1993284741","https://openalex.org/W2003265473","https://openalex.org/W2033390988","https://openalex.org/W2045685449","https://openalex.org/W2048195473","https://openalex.org/W2053121650","https://openalex.org/W2058555284","https://openalex.org/W2066660801","https://openalex.org/W2074448530","https://openalex.org/W2075361812","https://openalex.org/W2114659373","https://openalex.org/W2133755641","https://openalex.org/W2138689002","https://openalex.org/W2149435665","https://openalex.org/W2331354957","https://openalex.org/W2397791882"],"related_works":["https://openalex.org/W2905704223","https://openalex.org/W4319164487","https://openalex.org/W2555603121","https://openalex.org/W3207374610","https://openalex.org/W4393159832","https://openalex.org/W7162334587","https://openalex.org/W7221020093","https://openalex.org/W2943032213","https://openalex.org/W2915068397","https://openalex.org/W4407735658"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adherence":[1],"to":[2,46,154,252],"disease-modifying":[3],"therapy":[4],"(DMT)":[5],"remains":[6],"problematic":[7],"for":[8,97,246],"many":[9],"patients":[10,49,204,230,235],"with":[11,50,205,221,236,239],"multiple":[12],"sclerosis":[13],"(MS).":[14],"An":[15],"improved":[16],"understanding":[17],"of":[18,159,175],"factors":[19],"affecting":[20],"DMT":[21,37,77,90,150,155,160,176,189,222],"adherence":[22,78,161],"may":[23],"inform":[24],"effective":[25],"interventions.":[26],"This":[27],"study":[28],"examined":[29,118],"associations":[30],"between":[31,115,255],"treatment":[32,212],"satisfaction,":[33],"medication":[34,101,215],"beliefs,":[35],"and":[36,109,111,152,188,214,234],"adherence.":[38,223],"METHODS:":[39],"A":[40],"survey":[41,74],"was":[42,135],"mailed":[43],"in":[44,257],"2016":[45],"600":[47],"adult":[48],"relapsing-remitting":[51],"MS":[52,206,260],"taking":[53,147,231],"an":[54,148],"injectable":[55,149,232],"or":[56],"oral":[57],"DMT.":[58],"Patients":[59],"were":[60,117,142,162,217],"sampled":[61,207],"from":[62,208],"the":[63,93,104],"North":[64],"American":[65],"Research":[66],"Committee":[67],"on":[68,225],"Multiple":[69],"Sclerosis":[70],"(NARCOMS)":[71],"Registry.":[72],"The":[73],"measured":[75],"self-reported":[76],"(doses":[79],"taken":[80],"divided":[81],"by":[82],"doses":[83],"prescribed":[84],"during":[85],"previous":[86,237],"2-week":[87],"period-adherence":[88],"\u22650.80),":[89],"satisfaction":[91,213],"using":[92,103,119],"Treatment":[94],"Satisfaction":[95],"Questionnaire":[96],"Medication":[98],"version":[99],"II,":[100],"beliefs":[102,216],"Beliefs":[105],"About":[106],"Medicines":[107],"Questionnaire,":[108],"demographic":[110],"clinical":[112],"covariates.":[113],"Relationships":[114],"variables":[116,256],"multivariate":[120],"logistic":[121],"regression.":[122],"RESULTS:":[123],"Final":[124],"analyses":[125],"included":[126],"489":[127],"usable":[128],"surveys.":[129],"Mean":[130],"\u00b1":[131,137],"SD":[132],"participant":[133],"age":[134,163],"60.5":[136],"8.3":[138],"years.":[139],"Most":[140],"respondents":[141],"white":[143],"(93.8%),":[144],"female":[145],"(86.6%),":[146],"(66.9%),":[151],"adherent":[153],"(92.8%).":[156],"Significant":[157],"predictors":[158],"(odds":[164],"ratio":[165],"[OR],":[166],"1.086;":[167],"95%":[168,182,196],"CI,":[169,183,197],"1.020-1.158;":[170],"P":[171,185,199],"=":[172,186,200],".011),":[173],"type":[174],"(oral":[177],"vs.":[178,192],"injectable;":[179],"OR,":[180,194],"23.350;":[181],"2.254-241.892;":[184],".008),":[187],"experience":[190,238],"(naive":[191],"experienced;":[193],"2.831;":[195],"1.018-7.878;":[198],".046).":[201],"CONCLUSIONS:":[202],"In":[203],"a":[209],"patient":[210],"registry,":[211],"not":[218],"significantly":[219],"associated":[220],"Based":[224],"significant":[226],"predictors,":[227],"younger":[228],"patients,":[229],"DMTs,":[233],"another":[240],"DMT(s)":[241],"are":[242],"at":[243],"higher":[244],"risk":[245],"nonadherence.":[247],"Future":[248],"research":[249],"is":[250],"warranted":[251],"assess":[253],"relationships":[254],"more":[258],"diverse":[259],"populations.":[261]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2017-08-08T00:00:00"}